We understand that people with cancer are worried about coronavirus. Here is the latest guidance. We will update it regularly.

Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Chronic myeloid leukaemia (CML) TKIs and TFR. A guide for patients

Chronic myeloid leukaemia (CML) TKIs and TFR. A guide for patients (September 2018)

This booklet is written for patients with Philadelphiachromosome-positive (Ph+) CML. It explains what tyrokinase inhibitors are and how they work. It covers imatinib, nilotinib, dasatinib, bosutinib, ponatinib, including how they are given and possible side-effects.

Author(s)
Leukaemia Care
Place of publication
Worcester
Publisher
Date of publication
September 2018
Price
Free.
Format
Booklet
Language
English
Download this resource
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm